Therapeutic Three for Harlequin Ichthyosis
A study on topical Aminosalicylic Acid as a treatment for harlequin ichthyosis, a severe genetic disorder of ABCA12 gene that mainly affects the skin. Read more
A study on topical Aminosalicylic Acid as a treatment for harlequin ichthyosis, a severe genetic disorder of ABCA12 gene that mainly affects the skin. Read more
A study on Serinc1, a carrier protein that facilitates lipid synthesis that may influence immune cell functions and result in autoimmune diseases. Read more here.
An alternative to antibiotic treatment with minimal side effects for lung infection caused by multidrug-resistant (MDR) strain P. aeruginosa. Read more here.
Phenomics Australia (formerly the Australian Phenomics Network, APN) offers consolidated infrastructure and expertise supporting genomic medicine and biomedical research from discovery through into early clinical development and evaluation.
Phenomics Australia is a founding capability enabled by the National Collaborative Research Infrastructure Strategy (NCRIS). We would love to hear from you!
Please feel free to provide any ideas or general comments you might have so that we can further improve how Phenomics Australia can support you.
Have you recently had a publication accepted? Do you want to tell us about a grant you have received? Or maybe you have just been recently in the news? You can complete this form to tell us about your latest research developments.
Information provided will be used to inform press releases, website stories, social media content and more. This form is being used to capture everything that is happening at Phenomics Australia, which can then be used as part of our outreach and communications.
Once you have completed the form, the Communications and Outreach Coordinator will then be in contact with you.
Thanks.
_Get in touch to discuss how we can help with your research.